Margaret C. Cummings

7.9k total citations
74 papers, 3.2k citations indexed

About

Margaret C. Cummings is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Margaret C. Cummings has authored 74 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 29 papers in Cancer Research and 27 papers in Molecular Biology. Recurrent topics in Margaret C. Cummings's work include Cancer Genomics and Diagnostics (15 papers), Breast Cancer Treatment Studies (12 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Margaret C. Cummings is often cited by papers focused on Cancer Genomics and Diagnostics (15 papers), Breast Cancer Treatment Studies (12 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Margaret C. Cummings collaborates with scholars based in Australia, United States and United Kingdom. Margaret C. Cummings's co-authors include Michael D. Walsh, Sunil R. Lakhani, Michael A. McGuckin, Peter T. Simpson, Georgia Chenevix‐Trench, Nicholas K. Hayward, B Höhn, Ian Bennett, Neal I. Walker and Clay Winterford and has published in prestigious journals such as Circulation Research, JNCI Journal of the National Cancer Institute and Oncogene.

In The Last Decade

Margaret C. Cummings

73 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Margaret C. Cummings Australia 32 1.5k 1.4k 1.0k 735 383 74 3.2k
Thaer Khoury United States 32 1.1k 0.7× 1.5k 1.1× 1.1k 1.1× 675 0.9× 453 1.2× 153 3.1k
Paul van Diest Netherlands 23 1.5k 1.0× 1.4k 1.0× 1.0k 1.0× 513 0.7× 406 1.1× 49 3.2k
Takashi Fukutomi Japan 28 883 0.6× 1.2k 0.9× 1.2k 1.2× 813 1.1× 439 1.1× 163 3.1k
Paolo Michieli Italy 28 2.7k 1.8× 1.8k 1.3× 1.1k 1.0× 547 0.7× 503 1.3× 41 4.6k
Steven McKinney Canada 18 1.2k 0.8× 1.2k 0.9× 977 1.0× 346 0.5× 310 0.8× 30 2.9k
Marian Grade Germany 31 1.5k 1.0× 1.4k 1.0× 879 0.9× 570 0.8× 444 1.2× 85 3.0k
Alan B. Tuck Canada 39 2.1k 1.4× 1.5k 1.1× 1.1k 1.1× 448 0.6× 317 0.8× 74 4.2k
Bo Baldetorp Sweden 32 1.4k 0.9× 1.5k 1.1× 1.3k 1.3× 807 1.1× 757 2.0× 132 3.6k
Craig Allred United States 16 996 0.7× 1.7k 1.2× 1.5k 1.5× 528 0.7× 319 0.8× 19 3.1k
José A. Martínez-Climent Spain 39 1.9k 1.3× 1.3k 0.9× 784 0.8× 1.0k 1.4× 483 1.3× 135 4.5k

Countries citing papers authored by Margaret C. Cummings

Since Specialization
Citations

This map shows the geographic impact of Margaret C. Cummings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret C. Cummings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret C. Cummings more than expected).

Fields of papers citing papers by Margaret C. Cummings

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret C. Cummings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret C. Cummings. The network helps show where Margaret C. Cummings may publish in the future.

Co-authorship network of co-authors of Margaret C. Cummings

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret C. Cummings. A scholar is included among the top collaborators of Margaret C. Cummings based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret C. Cummings. Margaret C. Cummings is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Packer, Leisl, Vanessa Bonazzi, Robert J. Ju, et al.. (2017). PI3K Inhibitors Synergize with FGFR Inhibitors to Enhance Antitumor Responses in FGFR2mutant Endometrial Cancers. Molecular Cancer Therapeutics. 16(4). 637–648. 32 indexed citations
2.
Hendry, Shona, Jia‐Min Pang, David J. Byrne, et al.. (2017). Relationship of the Breast Ductal Carcinoma In Situ Immune Microenvironment with Clinicopathological and Genetic Features. Clinical Cancer Research. 23(17). 5210–5217. 57 indexed citations
3.
Bilous, Michael, Adrienne Morey, Jane E. Armes, et al.. (2012). Assessing HER2 amplification in breast cancer: findings from the Australian In Situ Hybridization Program. Breast Cancer Research and Treatment. 134(2). 617–624. 28 indexed citations
4.
Waldron, Levi, Shuji Ogino, Yujin Hoshida, et al.. (2012). Expression Profiling of Archival Tumors for Long-term Health Studies. Clinical Cancer Research. 18(22). 6136–6146. 25 indexed citations
5.
Cummings, Margaret C., et al.. (2011). Molecular classification of breast cancer: is it time to pack up our microscopes?. Pathology. 43(1). 1–8. 22 indexed citations
6.
Farshid, Gelareh, Jane E. Armes, Richard H. Bell, et al.. (2010). Establishment of the Australian In Situ Hybridization Program for the Assessment of HER2 Amplification in Breast Cancer. Diagnostic Molecular Pathology. 19(4). 187–193. 11 indexed citations
7.
Walsh, Michael D., Margaret C. Cummings, Daniel D. Buchanan, et al.. (2010). Lynch syndrome-associated breast cancers: clinicopathological characteristics of a case series from the colon CFR. Journal of Gastroenterology and Hepatology. 25. 1 indexed citations
8.
Cummings, Margaret C., et al.. (2010). Breast fine needle aspiration cytology: a review of current practice in Australasia. Cytopathology. 22(4). 269–275. 3 indexed citations
9.
Cummings, Margaret C., Leonard Da Silva, David Papadimos, & Sunil R. Lakhani. (2009). Fibroadenoma and intraduct papilloma—a common pathogenesis?. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 455(3). 271–275. 8 indexed citations
10.
Cummings, Margaret C.. (2003). Occult metastases in breast cancer. Queensland's institutional digital repository (The University of Queensland). 27(2). 95–97. 1 indexed citations
11.
Webb, Penelope M., Margaret C. Cummings, Christopher Bain, & C. M. Furnival. (2003). Changes in survival after breast cancer: improvements in diagnosis or treatment?. The Breast. 13(1). 7–14. 40 indexed citations
12.
Whiteman, David C., Xiaoping Zhou, Margaret C. Cummings, et al.. (2002). Nuclear PTEN expression and clinicopathologic features in a population‐based series of primary cutaneous melanoma. International Journal of Cancer. 99(1). 63–67. 154 indexed citations
13.
Bilous, Michael, Jane E. Armes, Richard H. Bell, et al.. (2001). Her2 Testing recommendations in Australia. Pathology. 33(4). 425–427. 14 indexed citations
14.
Cummings, Margaret C., Michaela Aubele, A. Mattis, et al.. (2000). Increasing chromosome 1 copy number parallels histological progression in breast carcinogenesis. British Journal of Cancer. 82(6). 1204–1210. 19 indexed citations
15.
Aubele, Michaela, Margaret C. Cummings, Axel Walch, et al.. (2000). Heterogeneous Chromosomal Aberrations in Intraductal Breast Lesions Adjacent to Invasive Carcinoma. Analytical Cellular Pathology. 20(1). 17–24. 28 indexed citations
16.
Aubele, Michaela, Margaret C. Cummings, A. Mattis, et al.. (2000). Accumulation of Chromosomal Imbalances From Intraductal Proliferative Lesions to Adjacent In Situ and Invasive Ductal Breast Cancer. Diagnostic Molecular Pathology. 9(1). 14–19. 49 indexed citations
17.
Webb, Penelope M., et al.. (1998). Relationship Between Number of Ovulatory Cycles and Accumulation of Mutant p53 in Epithelial Ovarian Cancer. JNCI Journal of the National Cancer Institute. 90(22). 1729–1734. 34 indexed citations
18.
Cummings, Margaret C., Clay Winterford, & Neal I. Walker. (1997). Apoptosis. The American Journal of Surgical Pathology. 21(1). 88–101. 121 indexed citations
19.
Dong, Ying, Michael D. Walsh, Michael A. McGuckin, et al.. (1997). Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product P16INK4A in ovarian cancer is associated with progression and unfavourable prognosis. International Journal of Cancer. 74(1). 57–63. 2 indexed citations
20.
Cummings, Margaret C.. (1995). Increased C- fos Expression Associated with Hyperthermia-induced Apoptosis of a Burkitt Lymphoma Cell Line. International Journal of Radiation Biology. 68(6). 687–692. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thaer Khoury Breakdown of academic impact, for papers by Paul van Diest Breakdown of academic impact, for papers by Takashi Fukutomi Breakdown of academic impact, for papers by Paolo Michieli Breakdown of academic impact, for papers by Steven McKinney Breakdown of academic impact, for papers by Marian Grade Breakdown of academic impact, for papers by Alan B. Tuck Breakdown of academic impact, for papers by Bo Baldetorp Breakdown of academic impact, for papers by Craig Allred Breakdown of academic impact, for papers by José A. Martínez-Climent
Rankless by CCL
2026